← Evidence map

ReviewCells2021

Multiple Therapeutic Applications of RBM-007, an Anti-FGF2 Aptamer.

Yoshikazu NakamuraPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

27 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34203430